Using cellular reprogramming technology, scientists have manipulated induced pluripotent stem cells (iPSCs) to create a library of robust, reproducible neural cells suitable for high-throughput screening.
View our webinar to learn how this new technology can enhance your translational CNS research with the ability to perform phenotypic screening with disease-relevant neural cells.
Mariangela Iovino, PhD
Group Leader, Integrated Biology
- Molecular and functional characterization of stem cells-derived glutamatergic cortical neurons (eNeuron/glut) in support of drug discovery applications (Poster)
- Cell Based Assays
- High Content Imaging
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.